Additionally, our research identified variants in genes such as ZNF521, ZNF717, RUNX2, and MMP16, which are implicated in bone mineralization and osteoblast differentiation, potentially explaining the higher fracture rates observed in hEDS patients. The gene discussed is ZNF717; the disease is Ehlers-Danlos syndrome, hypermobility type.